XML 28 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows provided by operating activities:    
Net income $ 65,056 $ 53,832
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 40,196 38,860
Amortization of deferred financing fees 923 2,924
Amortization of capitalized gift card sales commissions 7,604 6,690
Provision for impaired assets and restaurant closings 1,896 4,435
Accretion on debt discounts 653 173
Stock-based and other non-cash compensation expense 6,195 12,543
Income from operations of unconsolidated affiliates (2,858) (2,404)
Deferred income tax benefit 0 (333)
(Gain) loss on disposal of property, fixtures and equipment (318) 484
Unrealized (gain) loss on derivative financial instruments (263) 194
Gain on life insurance and restricted cash investments (1,944) (3,156)
Loss on extinguishment of debt 0 2,851
Recognition of deferred gain on sale-leaseback transaction (485) 0
Change in assets and liabilities:    
Decrease in inventories 10,201 886
(Increase) decrease in other current assets (5,167) 12,763
Decrease in other assets 2,530 2,447
Decrease in accounts payable and accrued and other current liabilities (12,827) (36,363)
Increase in deferred rent 2,836 2,834
Decrease in unearned revenue (97,245) (97,751)
Increase in other long-term liabilities 1,117 187
Net cash provided by operating activities 18,100 2,096
Cash flows (used in) provided by investing activities:    
Purchases of Company-owned life insurance (372) (350)
Proceeds from sale of Company-owned life insurance 38 0
Proceeds from disposal of property, fixtures and equipment 1,799 1,255
Proceeds from sale-leaseback transaction 0 192,886
Capital expenditures (40,950) (34,019)
Decrease in restricted cash 6,184 16,816
Increase in restricted cash (5,093) (21,100)
Return on investment from unconsolidated affiliates 0 332
Net cash (used in) provided by investing activities (38,394) 155,820
Cash flows used in financing activities:    
Proceeds from issuance of 2012 CMBS Loan 0 495,186
Repayments of long-term debt (30,558) (6,642)
Extinguishment of CMBS loan 0 (777,563)
Financing fees 0 (5,399)
Proceeds from the exercise of stock options 10,639 0
Distributions to noncontrolling interests (2,435) (4,160)
Repayments of partner deposits and accrued partner obligations (4,184) (9,242)
Issuance of notes receivable due from stockholders 0 (47)
Repayments of notes receivable due from stockholders 5,312 1,463
Net cash used in financing activities (21,226) (306,404)
Effect of exchange rate changes on cash and cash equivalents (2,701) 1,463
Net decrease in cash and cash equivalents (44,221) (147,025)
Cash and cash equivalents at the beginning of the period 261,690 482,084
Cash and cash equivalents at the end of the period 217,469 335,059
Supplemental disclosures of cash flow information:    
Cash paid for interest 19,975 13,420
Cash paid for income taxes, net of refunds 2,217 4,992
Supplemental disclosures of non-cash investing and financing activities:    
Conversion of partner deposits and accrued partner obligations to notes payable 325 2,646
Acquisition of property, fixtures and equipment through accounts payable or capital lease liabilities $ 1,199 $ 3,423